In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed at $8.41 down -1.52% from its previous closing price of $8.54. In other words, the price has decreased by -$1.52 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
For a deeper understanding of Avadel Pharmaceuticals plc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.97. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On June 12, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $27.
Oppenheimer reiterated its Outperform rating for the stock on March 05, 2024, while the target price for the stock was revised from $27 to $29.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 21 ’25 when Palczuk Linda bought 5,000 shares for $7.93 per share. The transaction valued at 39,640 led to the insider holds 67,900 shares of the business.
Thornton Peter J. bought 10,000 shares of AVDL for $80,450 on Jan 13 ’25. The Director now owns 104,055 shares after completing the transaction at $8.04 per share. On Jan 13 ’25, another insider, Ende Eric J, who serves as the Director of the company, bought 30,000 shares for $7.84 each. As a result, the insider paid 235,218 and bolstered with 208,900 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.87 while its Price-to-Book (P/B) ratio in mrq is 10.85.
Stock Price History:
Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $7.39. The 50-Day Moving Average of the stock is -8.70%, while the 200-Day Moving Average is calculated to be -36.71%.
Shares Statistics:
A total of 96.34M shares are outstanding, with a floating share count of 88.09M. Insiders hold about 8.59% of the company’s shares, while institutions hold 79.97% stake in the company.
